{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:04:43Z","timestamp":1780376683169,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00535-026-02403-7","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:37:08Z","timestamp":1775101028000},"page":"796-807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative diagnostic performance of ultrasound-guided attenuation parameter versus B-mode scoring for hepatic steatosis assessment: an ordinal-scale statistical approach"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2211-495X","authenticated-orcid":false,"given":"Takashi","family":"Kumada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1652-6168","authenticated-orcid":false,"given":"Hidenori","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2916-5875","authenticated-orcid":false,"given":"Sadanobu","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8097-0757","authenticated-orcid":false,"given":"Tatsuya","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7081-5625","authenticated-orcid":false,"given":"Yasuaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1931-6326","authenticated-orcid":false,"given":"Kento","family":"Imajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7815-549X","authenticated-orcid":false,"given":"Masato","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6271-7806","authenticated-orcid":false,"given":"Katsutoshi","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1471-1087","authenticated-orcid":false,"given":"Hidekatsu","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4634-6616","authenticated-orcid":false,"given":"Nobuharu","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7016-8931","authenticated-orcid":false,"given":"Masayuki","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1056-3611","authenticated-orcid":false,"given":"Tomoyuki","family":"Akita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5669-4051","authenticated-orcid":false,"given":"Junko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6263-1436","authenticated-orcid":false,"given":"Atsushi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"2403_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384.","journal-title":"Hepatology"},{"key":"2403_CR2","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78:1966\u201386.","journal-title":"Hepatology"},{"key":"2403_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1056\/NEJM200102153440706","volume":"344","author":"AA Bravo","year":"2001","unstructured":"Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495\u2013500.","journal-title":"N Engl J Med"},{"key":"2403_CR4","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","volume":"128","author":"V Ratziu","year":"2005","unstructured":"Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128:1898\u2013906.","journal-title":"Gastroenterology"},{"key":"2403_CR5","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1148\/radiol.12120896","volume":"267","author":"A Tang","year":"2013","unstructured":"Tang A, Tan J, Sun M, et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology. 2013;267:422\u201331.","journal-title":"Radiology"},{"key":"2403_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1148\/radiol.2017170550","volume":"286","author":"T Yokoo","year":"2018","unstructured":"Yokoo T, Serai SD, Pirasteh A, et al. Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis. Radiology. 2018;286:486\u201398.","journal-title":"Radiology"},{"key":"2403_CR7","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","volume":"102","author":"M Hamaguchi","year":"2007","unstructured":"Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102:2708\u201315.","journal-title":"Am J Gastroenterol"},{"key":"2403_CR8","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1478-3231.2012.02804.x","volume":"32","author":"S Ballestri","year":"2012","unstructured":"Ballestri S, Lonardo A, Romagnoli D, et al. Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. Liver Int. 2012;32:1242\u201352.","journal-title":"Liver Int"},{"key":"2403_CR9","doi-asserted-by":"publisher","first-page":"W320","DOI":"10.2214\/AJR.07.2123","volume":"189","author":"S Strauss","year":"2007","unstructured":"Strauss S, Gavish E, Gottlieb P, Katsnelson L. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR Am J Roentgenol. 2007;189:W320\u20133.","journal-title":"AJR Am J Roentgenol"},{"key":"2403_CR10","first-page":"5453","volume":"7","author":"M Cengiz","year":"2014","unstructured":"Cengiz M, Sent\u00fcrk S, Cetin B, et al. Sonographic assessment of fatty liver: intraobserver and interobserver variability. Int J Clin Exp Med. 2014;7:5453\u201360.","journal-title":"Int J Clin Exp Med"},{"key":"2403_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2214\/AJR.18.20123","volume":"212","author":"T Tada","year":"2019","unstructured":"Tada T, Kumada T, Toyoda H, et al. Utility of attenuation coefficient measurement using an ultrasound-guided attenuation parameter for evaluation of hepatic steatosis: comparison with MRI-determined proton density fat fraction. AJR Am J Roentgenol. 2019;212:332\u201341.","journal-title":"AJR Am J Roentgenol"},{"key":"2403_CR12","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.cgh.2021.11.003","volume":"20","author":"K Imajo","year":"2022","unstructured":"Imajo K, Toyoda H, Yasuda S, et al. Utility of ultrasound-guided attenuation parameter for grading steatosis with reference to MRI-PDFF in a large cohort. Clin Gastroenterol Hepatol. 2022;20:2533\u201341.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2403_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1148\/radiol.212808","volume":"305","author":"DT Fetzer","year":"2022","unstructured":"Fetzer DT, Rosado-Mendez IM, Wang LM, et al. Pulse-echo quantitative US biomarkers for liver steatosis: toward technical standardization. Radiology. 2022;305:265\u201376.","journal-title":"Radiology"},{"key":"2403_CR14","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1016\/j.ultrasmedbio.2018.06.017","volume":"44","author":"Y Fujiwara","year":"2018","unstructured":"Fujiwara Y, Kuroda H, Abe T, et al. The B-mode image-guided ultrasound attenuation parameter accurately detects hepatic steatosis in chronic liver disease. Ultrasound Med Biol. 2018;44:2223\u201332.","journal-title":"Ultrasound Med Biol"},{"key":"2403_CR15","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics"},{"key":"2403_CR16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","volume":"148","author":"JA Hanley","year":"1983","unstructured":"Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839\u201343.","journal-title":"Radiology"},{"key":"2403_CR17","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.acra.2005.05.013","volume":"12","author":"NA Obuchowski","year":"2005","unstructured":"Obuchowski NA. Estimating and comparing diagnostic tests\u2019 accuracy when the gold standard is not binary. Acad Radiol. 2005;12:1198\u2013204.","journal-title":"Acad Radiol"},{"key":"2403_CR18","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1002\/sim.4044","volume":"29","author":"CT Nakas","year":"2010","unstructured":"Nakas CT, Alonzo TA, Yiannoutsos CT. Accuracy and cut-off point selection in three-class classification problems using a generalization of the Youden index. Stat Med. 2010;29:2946\u201355.","journal-title":"Stat Med"},{"key":"2403_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1080\/10543406.2019.1632876","volume":"30","author":"J Hua","year":"2020","unstructured":"Hua J, Tian L. A comprehensive and comparative review of optimal cut-points selection methods for diseases with multiple ordinal stages. J Biopharm Stat. 2020;30:98\u2013114.","journal-title":"J Biopharm Stat"},{"key":"2403_CR20","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/hep.24268","volume":"53","author":"ZM Younossi","year":"2011","unstructured":"Younossi ZM, Stepanova M, Rafiq N, et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology. 2011;53:1874\u201382.","journal-title":"Hepatology"},{"key":"2403_CR21","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/aab4b1","volume":"63","author":"NA Obuchowski","year":"2018","unstructured":"Obuchowski NA, Bullen JA. Receiver operating characteristic (ROC) curves: review of methods with applications in diagnostic medicine. Phys Med Biol. 2018;63:07TR01. https:\/\/doi.org\/10.1088\/1361-6560\/aab4b1.","journal-title":"Phys Med Biol"},{"key":"2403_CR22","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1056\/NEJM197810262991705","volume":"299","author":"DF Ransohoff","year":"1978","unstructured":"Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med. 1978;299:926\u201330.","journal-title":"N Engl J Med"},{"key":"2403_CR23","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1002\/sim.944","volume":"20","author":"NA Obuchowski","year":"2001","unstructured":"Obuchowski NA, Goske MJ, Applegate KE. Assessing physicians\u2019 accuracy in diagnosing paediatric patients with acute abdominal pain: measuring accuracy for multiple diseases. Stat Med. 2001;20:3261\u201378.","journal-title":"Stat Med"},{"key":"2403_CR24","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1373\/clinchem.2007.097923","volume":"54","author":"J Lambert","year":"2008","unstructured":"Lambert J, Halfon P, Penaranda G, et al. How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited. Clin Chem. 2008;54:1372\u20138.","journal-title":"Clin Chem"},{"key":"2403_CR25","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/jum.15154","volume":"39","author":"SM Nelson","year":"2020","unstructured":"Nelson SM, Hoskins JD, Lisanti C, et al. Ultrasound fatty liver indicator: a simple tool for differentiating steatosis from nonalcoholic steatohepatitis: validity in the average obese population. J Ultrasound Med. 2020;39:749\u201359.","journal-title":"J Ultrasound Med"},{"key":"2403_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/jmri.22580","volume":"34","author":"SB Reeder","year":"2011","unstructured":"Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging. 2011;34:729\u201349.","journal-title":"J Magn Reson Imaging"},{"key":"2403_CR27","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","volume":"150","author":"K Imajo","year":"2016","unstructured":"Imajo K, Kessoku T, Honda Y, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016;150:626\u201337.","journal-title":"Gastroenterology"},{"key":"2403_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-166","volume":"12","author":"B van Zaane","year":"2012","unstructured":"van Zaane B, Vergouwe Y, Donders AR, et al. Comparison of approaches to estimate confidence intervals of post-test probabilities of diagnostic test results in a nested case-control study. BMC Med Res Methodol. 2012;12:166. https:\/\/doi.org\/10.1186\/1471-2288-12-166.","journal-title":"BMC Med Res Methodol"},{"key":"2403_CR29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"2403_CR30","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.ultrasmedbio.2019.02.008","volume":"45","author":"SK Jeon","year":"2019","unstructured":"Jeon SK, Lee JM, Joo I, et al. Prospective evaluation of hepatic steatosis using ultrasound attenuation imaging in patients with chronic liver disease with magnetic resonance imaging proton density fat fraction as the reference standard. Ultrasound Med Biol. 2019;45:1407\u201316.","journal-title":"Ultrasound Med Biol"},{"key":"2403_CR31","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","volume":"36","author":"M Sasso","year":"2010","unstructured":"Sasso M, Beaugrand M, de Ledinghen V, et al. Controlled attenuation parameter (CAP): a novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis. Ultrasound Med Biol. 2010;36:1825\u201335.","journal-title":"Ultrasound Med Biol"},{"key":"2403_CR32","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","volume":"66","author":"T Karlas","year":"2017","unstructured":"Karlas T, Petroff D, Sasso M, et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66:1022\u201330.","journal-title":"J Hepatol"},{"key":"2403_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-019-0961-9","volume":"19","author":"K Pu","year":"2019","unstructured":"Pu K, Wang Y, Bai S, et al. Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis. BMC Gastroenterol. 2019;19:51. https:\/\/doi.org\/10.1186\/s12876-019-0961-9.","journal-title":"BMC Gastroenterol"},{"key":"2403_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.14366\/usg.25127","volume":"45","author":"K Imajo","year":"2026","unstructured":"Imajo K, Toyoda H, Yasuda S, et al. Direct comparison of ultrasound-guided attenuation parameter and controlled attenuation parameter for steatosis using MRI-based proton density fat fraction as a reference. Ultrasonography. 2026;45:9\u201316.","journal-title":"Ultrasonography"},{"key":"2403_CR35","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.ultrasmedbio.2018.07.019","volume":"44","author":"A Ozturk","year":"2018","unstructured":"Ozturk A, Grajo JR, Gee MS, et al. Quantitative hepatic fat quantification in non-alcoholic fatty liver disease using ultrasound-based techniques: a review of literature and their diagnostic performance. Ultrasound Med Biol. 2018;44:2461\u201375.","journal-title":"Ultrasound Med Biol"},{"key":"2403_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.soard.2017.09.005","volume":"14","author":"H Garg","year":"2018","unstructured":"Garg H, Aggarwal S, Shalimar, et al. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients. Surg Obes Relat Dis. 2018;14:81\u201391.","journal-title":"Surg Obes Relat Dis"},{"key":"2403_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1023\/A:1010920819831","volume":"45","author":"DJ Hand","year":"2001","unstructured":"Hand DJ, Till RJ. A simple generalisation of the area under the ROC curve for multiple class classification problems. Mach Learn. 2001;45:171\u201386.","journal-title":"Mach Learn"},{"key":"2403_CR38","doi-asserted-by":"crossref","unstructured":"Ferri C, Hern\u00e1ndez-Orallo J, Salido MA. Volume under the ROC Surface for Multi-class Problems. Machine Learning: ECML. 2003;108\u201320.","DOI":"10.1007\/978-3-540-39857-8_12"},{"key":"2403_CR39","doi-asserted-by":"publisher","first-page":"90","DOI":"10.2214\/AJR.18.20947","volume":"213","author":"BD Pooler","year":"2019","unstructured":"Pooler BD, Hernando D, Reeder SB. Clinical implementation of a focused MRI protocol for hepatic fat and iron quantification. AJR Am J Roentgenol. 2019;213:90\u20135.","journal-title":"AJR Am J Roentgenol"},{"key":"2403_CR40","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/hep.29596","volume":"67","author":"MS Middleton","year":"2018","unstructured":"Middleton MS, Van Natta ML, Heba ER, et al. Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease. Hepatology. 2018;67:858\u201372.","journal-title":"Hepatology"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02403-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-026-02403-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02403-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:57:35Z","timestamp":1779955055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-026-02403-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2403"],"URL":"https:\/\/doi.org\/10.1007\/s00535-026-02403-7","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Takashi Kumada received research grants from GE Healthcare. Kento Imajo, Hidenori Toyoda, Hidekatsu Kuroda, Masato Yoneda, and Atsushi Nakajima have no competing interests to disclose. All authors had full access to the data in the study and accept responsibility to submit for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This prospective study was approved by the institutional review board of Ogaki Municipal Hospital (approval number 20221124\u20137-h) and was conducted in compliance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all participants involved in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}},{"value":"This research does not involve the reproduction or use of material from other sources.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material from other sources"}},{"value":"This study was registered in the University Hospital Medical Information Network (UMIN) Clinical Trials Registry (UMIN000041196).Fig. S1 Components of the Hamaguchi Score. Representative ultrasound images demonstrating the three components of the Hamaguchi scoring system using standardized LOGIQ E10 ultrasound system. (a) Hepatorenal contrast and liver brightness evaluation: scores of 0\u20133 are defined based on an echogenicity comparison with the renal cortex and visualization of the intrahepatic structures. (b) Deep-beam attenuation assessment: scores of 0\u20132 are defined based on posterior liver visualization and diaphragm clarity. (c) Vessel blurring evaluation: scores of 0\u20131 are defined based on the intrahepatic vessel border definition and wall clarity.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}}]}}